ROLE OF CHEMOTHERAPY IN THE MANAGEMENT OF ADVANCED MALIGNANT OVARIAN TUMOURS

ABSTRACT: | Full Text PDF

OBJECTIVE: To assess the role of adjuvant chemotherapy after surgical management of advanced malignant ovarian cancers in prognosis and survival of patients

METHODOLOGY: This prospective observational study was performed to analyse the treatment of all cases of Malignant ovarian tumours, diagnosed and treated at the department of Gynaecology and obstetrics, Jinnah Postgraduate medical centre, in collaboration of Oncology department Jinnah Postgraduate medical centre Karachi, during January 2001 till June 2002. After obtaining informed consent, patients with diagnosed malignant ovarian tumors were enrolled in the study, patients with co-morbidities or failed to give consent were excluded from the study. The profile consists of a thorough history, physical examination, investigations and diagnosis as were recorded in Performa. Data was analyzed by SPSS version 17.

RESULTS: During the study period, total 16 cases of ovarian malignancy were diagnosed and treated. Total Gynaecological malignancies admitted during this study period were 70. Among these ovarian malignancy was the second commonest with 22.85% incidence rate following cervical cancers (i.e, 54.28%). All the patients underwent laparotomy supported by adjuvant chemotherapy in majority of cases. All patients were followed for a minimum period of six months

CONCLUSION: Majority of the patients are reported with advanced disease at the time of diagnosis, i.e that is why these patients cannot be treated with surgery alone. Consequently, adjuvant chemotherapy has become a major treatment modality for this disease in advance stages.

Uncategorized